In-vitro investigation of susceptibilities to griseofulvin, fluconazole and itraconazole of various dermatophytes;Çeşitli dermatofitlerin griseofulvin, flukonazol ve itrakonazol duyarliliklarinin in-vitro araştirilmasi

Mikrobiyoloji Bulteni

Volumn 35, Issue 2, 2001, Pages 299-305

  Kibar, F ^a   Koksal F ^a   Acar, A ^a   Akbaba, M ^a   Yoldascan E ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Antifungal agent; Dermatophyte; Susceptibility test

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DERMATOMYCOSIS; DERMATOPHYTE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON TONSURANS; TRICHOPHYTON VERRUCOSUM; TRICHOPHYTON VIOLACEUM;

EID: 17344378715     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. In vitro evaluation of griseofulvin, ketoconazole and itraconazole against various dermatophytes in Singapore
2. Problems of resistant dermatophytoses
3. Dermatophytes and agents of superficial mycoses
4. Is antifungal resistance testing necessary?
5. In vitro assessment of antifungal drug resistance
6. Laboratory studies with antifungal agents: Susceptibility tests and quantitation in body fluids
7. Microdilution susceptibility testing of amphotericin B, itraconazole against clinical isolates of Aspergillus and Fusarium species
8. Minireview: Antifungal susceptibility tests
9. Antifungal susceptibility testing with dermatophytes
10. Clinical utility of in vitro antifungal susceptibility testing
11. Comparative randomized double-blind study of itraconazole and griseofulvin in Tinea corporis and Tinea cruris
12. Griseofulvin resistant dermatophytosis correlates with in vitro resistance
13. Çeşitli dermatofit ve mayalarin bazi antifungal maddelere duyarliliklarinin denenmesi ve sonuçlari etkileyen bir kisim faktörlerin araştirilmasi
14. In vitro susceptibility of dermatophytes to antifungal drugs: A comparison of two methods
15. Disk diffusion susceptibility testing of dermatophytes with imidazoles
16. Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome
17. Plasma and tissue concentrations of fluconazole: Discussion of breakpoint problem
18. Plasma and tissue concentrations of fluconazole and their correlation to breakpoints
19. Dermatofitlerin griseofulvin, ketokonazol ve itrakonazole in vitro duyarliliklari. CCVI
20. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole
21. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes
22. In-vitro antifungal activity of itrakonazol, a new triazol antifungal agent, against clinical isolates from patients with dermatomycoses
23. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method
24. Antimicrobial susceptibility testing of dermatophytes. Comparison of the agar macrodilution and broth microdilution tests
25. Evaluation of the susceptibility of dermatophytes to antifungal drugs: A new technique
26. Preliminary evalution of a semisolid agar antifungal susceptibility test for yeast and mold
27. Standardization of antifungal susceptibility testing and clinical relevance